NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Laura Q Rogers

Enhancing Physical Activity After Breast Cancer Diagnosis: Randomized Trial

Breast

Stuart Hogarth

DNA patents beyond clinical genetics: HPV testing and cervical cancer screening in China, the UK and USA. A comparative investigation of the bioethics of biomarker IP and its implications for public p

Oesophagus Cervix uteri Nasopharynx

Donna Reece

Expediting Patient-Oriented Research in Canada: Development of Myeloma Canada Research Network (MCRN)

Multiple myeloma and immunoproliferative diseases

Matthew Davis

Classification and functional annotation of endogenous siRNAs and other small RNAs

Breast

Farrel J Buckinsky

Genetic Susceptibility of Papilloma-Induced Voice Disturbance

Cervix uteri

Ulrike Peters

Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO); Colorectal Transdisciplinary (CORECT) Study

Colorectum

Thomas J O'Hare

Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia

Leukaemia

Pathology Hematology and hematologic malignancies

Steven M Dubinett

The UCLA-Boston University Lung Cancer Biomarker Development Laboratory

Trachea, bronchus and lung

Pathology

Ruth E Patterson

Energetics & Breast Cancer: Obesity, Inflammation, Insulin Resistance & Risk

Breast